|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 498/18 | (2006.01) |
| A61K 31/395 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 3813946 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19819402.9 |
| Date of filing the European patent application | 2019-06-17 | |
| (97) | Date of publication of the European application | 2021-05-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-22 |
| (46) | Date of publication of the claims translation | 2024-07-10 |
| (86) | Number | PCT/US2019/037507 |
| Date | 2019-06-17 |
| (87) | Number | WO 2019/241789 |
| Date | 2019-12-19 |
| (30) | Number | Date | Country code |
| 201862685666 P | 2018-06-15 | US |
| (72) |
SAIAH, Eddine , US
O'NEILL, David, John , US
KANG, Seong Woo Anthony , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Rapamicino analogai ir jų panaudojimas |
| RAPAMYCIN ANALOGS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-19 | 7 | 162.00 EUR |
| 2026-06-17 |